Multifunctional nanocomposites utilizing ruthenium (II) complex/manganese (IV) dioxide nanoparticle for synergistic reinforcing radioimmunotherapy
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Radiotherapy (RT) stands as a frontline treatment modality in clinical breast oncology, yet challenges like ROS reduction, high toxicity, non-selectivity, and hypoxia hinder efficacy. Additionally, RT administered at different doses can induce varying degrees of radioimmunotherapy. High doses of radiation (>10 Gy) may result in immune suppression, while moderate doses (4–10 Gy), although capable of mitigating the immune suppression caused by high-dose radiation, are often insufficient in effectively killing tumor cells. Therefore, enhancing the generation of ROS and ameliorating the tumor hypoxic immune-suppressive microenvironment at moderate radiation doses could potentially drive radiation-induced immune responses, offering a fundamental solution to the limitations of RT. In this study, a novel multifunctional nanoplatform, RMLF, integrating a Ru (II) complex into folate-functionalized liposomes with BSA-MnO 2 nanoparticles was proposed. Orthogonal experimental optimization enhances radiosensitization via increasing accumulation in cancer cells, elevating ROS, and contributing to a dual enhancement of the cGAS-STING-dependent type I IFN signaling pathway, aimed to overcome the insufficient DAMPs typically seen in the conventional RT at 4 Gy. Such a strategy effectively activated cytotoxic T lymphocytes for infiltration into tumor tissues and promoted the polarization of tumor-associated macrophages from the M2 to M1 phenotype, substantially bolstering immune memory responses. This pioneering approach represents the first use of a ruthenium complex in radioimmunotherapy, activating the cGAS-STING pathway to amplify immune responses, overcome RT resistance, and extend immunotherapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig. 2 RMLF relieves hypoxic TME and actively targets 4T1 cells. (a)Typical oxygen generation kinetics curves of RL, RML, RMLF and MnB in the presence of H2O2 ([Mn] = 10 µg/mL, [H2O2] = 1 mM) (b, d) Quantitative analysis of the fluorescence intensity of MnB and MnB with 100 µM H2O2 by Image J (n = 3). IFM images of 4T1 cells treated with MnB ([Mn] = 10 µg/mL) for 24 h with or without H2O2 (100 µM) and stained with RDPP as an O2 probe, respectively. The scale bar represents 200 μm. (c, e) Quantitative analysis of the HIF-1α fluorescence intensity of more than 100 cells in each group by Image J (n = 3). Hypoxia-relieving efficacy of RMLF (2 µM RudZ, [Mn] = 10 µg/mL) assessed by HIF-1α immunofluorescence. The scale bar represents 50 μm. (f, g) In vitro uptake of RudZ and different liposome-based samples (2 µM RudZ) on 4T1 cells analyzed by IFM. The scale bar represents 200 μm. Quantitative analysis of the fluorescence intensity of RudZ and different liposome samples by Image J (n = 3). *** indicates p < 0.001; **** indicates p < 0.0001](https://figures.cochat.ai/paper-figures/3d762c3018514e5cad87765666170c21/multifunctional-nanocomposites-utilizing-ruthenium-ii-complex-manganese-iv-figure-2.jpg)
![Fig. 3 Evaluation of radiotherapy sensitizing activity of RMLF in vitro. (a) Cell viability of 4T1 cells treated with the RudZ (2 µM), CDDP (2 µM), MnB ([Mn] = 10 µg/mL), RML (2 µM RudZ, [Mn] = 10 µg/mL) and RMLF (2 µM RudZ, [Mn] = 10 µg/mL) (n = 3). The dose of X-ray is 4 Gy. (b, e) The quantitative analysis of survival fraction (SF) from clone formation under different treatments (n = 3). And optical photographs of clonogenic survival assay under different treatments. (c, f) Quantitative analysis of the γ-H2AX fluorescence intensity of more than 100 cells in each group by Image J (n = 3). The DNA damage effect of RMLF (2 µM RudZ, [Mn] = 10 µg/mL) was assessed by γ-H2AX immunofluorescence. The scale bars represent 200 μm. (d) Flow cytometry was employed to perform cell cycle analysis of 4T1 cells subjected to different treatments. *** indicates p < 0.001; **** indicates p < 0.0001](https://figures.cochat.ai/paper-figures/5dac25aba0664c83b89e0a8d33a1f805/multifunctional-nanocomposites-utilizing-ruthenium-ii-complex-manganese-iv-figure-3.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Immune-related effects, including immunogenic cell death, dendritic cell activation, macrophage polarization, and cGAS–STING signaling, were also described in selected studies [23,26,91].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [91]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Immune-related effects, including cGAS–STING activation and increased immune cell infiltration, have also been described following nanoparticle-assisted irradiation [18,23,26,91].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792 · cited 1×
“As cells expressing CD86 and CD80 are markers of DCs maturation [57], we used flow cytometry to analyze the effect of RMLF + X-ray treatment of 4T1 cells to induce DCs maturation.”
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Vanpouille-Box, C., Alard, A., Aryankalayil, M. J., Sarfraz, Y., Diamond, J. M., Schneider, R. J., Inghirami, G., Coleman, C. N., Formenti, S. C., & Demaria, S. (2017) · Nature Communications · doi:10.1038/ncomms15618 · Cited by 1,834
DNA sensing by the cGAS–STING pathway in health and disease
Motwani, M., Pesiridis, S., & Fitzgerald, K. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0151-1 · Cited by 1,467 · cited 1×
“Upon activation of the cGAS-STING intrinsic immune signaling pathway, NF-κB expression induces the expression of IFNs and other immune-related cytokines, thereby inducing the maturation of DCs and increasing the proportion of CD8 + T cells [56].”
Lin, L., Song, J., Song, L., Ke, K., Liu, Y., Zhou, Z., Shen, Z., Li, J., Yang, Z., Tang, W., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712027 · Cited by 1,466
A molecular light switch for DNA: Ru(bpy)2(dppz)2+
Friedman, A. E., Chambron, J. C., Sauvage, J. P., Turro, N. J., & Barton, J. K. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00168a052 · Cited by 1,412 · cited 1×
“It is well known that dppz-derived ruthenium complexes can act as molecular light switches [30], therefore, we examined the properties of RudZ using Lipo as the assembly medium.”
BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis
McArthur, K., Whitehead, L. W., Heddleston, J. M., Li, L., Padman, B. S., Oorschot, V., Geoghegan, N. D., Chappaz, S., Davidson, S., San Chin, H., et al. (2018) · Science · doi:10.1126/science.aao6047 · Cited by 1,072 · cited 1×
“The mechanism of mitochondrial release of mtDNA may be closely related to the BAX/BAK protein pathway [55].”
Zeng, L., Gupta, P., Chen, Y., Wang, E., Ji, L., Chao, H., & Chen, Z.-S. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00195a · Cited by 1,017 · cited 1×
“Besides platinum-containing complexes, ruthenium polypyridyl complexes (RPCs) have been heavily studied for their dsDNA-binding, potential anticancer activity, and adjustable spectroscope and photophysical properties [7–10].”
Sun, X., Zhang, Y., Li, J., Park, K. S., Han, K., Zhou, X., Xu, Y., Nam, J., Xu, J., Shi, X., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00962-9 · Cited by 788 · cited 1×
“Recently, Mn 2+ is being exploited to activate the cGAS-STING mediated IFNs [54].”
Self-citation
Cited by
Chen, D., Liu, A., Wang, Z., Wang, C., Hu, J., Wang, D., & Yao, D. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.217976 · Cited by 4
Rong, J., Lv, F., Wang, R., Li, H., Zhang, Q., & Hu, X. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.5c00688 · Cited by 4
Progress and prospects of metal-based immunotherapy in breast cancer
Liang, J., Yang, X., & Zhang, Y. (2025) · BioMetals · doi:10.1007/s10534-025-00747-w · Cited by 3
“Additionally, a novel multifunctional nanoplatform, RMLF, combining rhodium (II) complexes with BSA-MnO ₂ nanoparticles, has been developed to enhance ROS generation and activate the cGAS-STING pathway, thereby improving immune responses during radiotherapy (Peng et al. 2024).”
Mechanisms and Applications of Manganese-Based Materials in Tumor Immunotherapy
Kong, X., Zhang, C., Hu, H., Chen, Y., Gao, W., & Chen, R. (2026) · Molecules · doi:10.3390/molecules31101704 · Cited by 3
“This effectively promotes CTL infiltration and the polarization of macrophages from M2 to M1, significantly enhancing immune memory responses and overcoming the issue of insufficient DAMP release during conventional RT (4 Gy) [110].”
Jiang, M., Chen, M., Zou, W., Xie, Y., Shi, J., Liu, J., Chen, A., & Zhao, X. R. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.11.012 · Cited by 1
Metadata
- Authors
- Peng, J., Quan, D.-L., Yang, G., Wei, L.-T., Yang, Z., Dong, Z.-Y., Zou, Y.-M., Hou, Y.-K., Chen, J.-X., Lv, L., & Sun, B.
- Affiliations
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Southern Medical University Shenzhen Hospital (CN)
- Jinan University (CN)
- Southern Medical University (CN)
- Corresponding author
- Lv, Lin
- Sun, Bin
- Venue
- Journal of Nanobiotechnology
- Published
- 2024-11-27
- Volume
- 22
- Issue
- 1
- Pages
- 735-735
- ISSN
- 1477-3155 (ISSN-L)
- PMC
- PMC11600833
- OpenAlex
- W4404731262
- Cited by
- 9
- References
- 63
- Citations by year
- 2026: 6 · 2025: 3
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Journal of Nanobiotechnology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- the Characteristic Innovation Projects of Colleges and Universities in Guangdong Province (2018KTSCX028)
- the Open Funding of MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, Sun Yat-Sen University (BISC2022A03)
- the Student Innovation and Entrepreneurship Training Program Project of Southern Medical University (S202212121191)
- National Natural Science Foundation of China (82204415)
- the Guangdong Basic and Applied Basic Research Foundation (2021A1515220187)
- Guangdong Science and Technology Department of China (2023A1515012633)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- radioimmunotherapy, ruthenium(II) complexes, manganese dioxide nanoparticles, radiosensitization, reactive oxygen species, tumor hypoxia, cGAS-STING pathway, type I interferon signaling, radiation-induced immune response, tumor-associated macrophage polarization, cytotoxic T lymphocytes, breast cancer, nanocomposite drug delivery
- MeSH terms
- Multifunctional Nanoparticles, Animals, Breast Neoplasms, Female, Humans, Liposomes, Mice, Inbred BALB C, Oxides, Radiation-Sensitizing Agents, Ruthenium, Radioimmunotherapy, Reactive Oxygen Species, Manganese Compounds, Cell Line, Tumor, Mice, Nanoparticles, Nanocomposites, Coordination Complexes, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multifunctional nanocomposites utilizing ruthenium (II) complex/manganese (IV) dioxide nanoparticle for synergistic reinforcing radioimmunotherapy. https://app.cochat.ai/papers/10.1186/s12951-024-03013-2
- The paper
- Peng, J., Quan, D.-L., Yang, G., Wei, L.-T., Yang, Z., Dong, Z.-Y., Zou, Y.-M., Hou, Y.-K., Chen, J.-X., Lv, L., & Sun, B. (2024). Multifunctional nanocomposites utilizing ruthenium (II) complex/manganese (IV) dioxide nanoparticle for synergistic reinforcing radioimmunotherapy. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-024-03013-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.